Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

55 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
[Asthma 2020 Nursing Consensus Document].
Vaquero-Lozano P, Lassaletta-Goñi I, Giner-Donaire J, Gómez-Neira MDC, Serra-Batlles J, García-García R, Álvarez-Gutiérrez FJ, Blanco-Aparicio M, Díaz-Pérez D. Vaquero-Lozano P, et al. Open Respir Arch. 2021 Jan 8;3(1):100079. doi: 10.1016/j.opresp.2020.100079. eCollection 2021 Jan-Mar. Open Respir Arch. 2021. PMID: 37497358 Free PMC article. Spanish.
Management of asthma in the emergency department: a consensus statement.
Piñera Salmerón P, Delgado Romero J, Domínguez Ortega J, Labrador Horrillo M, Álvarez Gutiérrez FJ, Martínez Moragón E, Plaza Moral V, Álvarez Rodríguez C, Miguel Franco J. Piñera Salmerón P, et al. Emergencias. 2018 Ago;30(4):268-277. Emergencias. 2018. PMID: 30033702 Free article. English, Spanish.
[The management of asthma as a chronic inflammatory disease and global health problem: A position paper from the scientific societies].
Domínguez-Ortega J, Sáez-Martínez FJ, Gómez-Sáenz JT, Molina-París J, Álvarez-Gutiérrez FJ; en nombre del Grupo Unidos por el Asma; Grupo Unidos por el Asma. Domínguez-Ortega J, et al. Semergen. 2020 Jul-Aug;46(5):347-354. doi: 10.1016/j.semerg.2020.01.001. Epub 2020 Mar 26. Semergen. 2020. PMID: 32224055 Spanish.
Unmet therapeutic goals and potential treatable traits in a population of patients with severe uncontrolled asthma in Spain. ENEAS study.
Pérez de Llano L, Martínez-Moragón E, Plaza Moral V, Trisan Alonso A, Sánchez CA, Callejas FJ, Vera E, Soto Campos JG, Martinez Rivera C, Alcázar Navarrete B, Urrutia Landa I, Garcia Rivero JL, Padilla Galo A, Alvarez Gutierrez F, Landete P, Ramos González J, Aracil CF, Carretero Gracia JÁ, Lluch I, Puente L, Andujar-Espinosa R, Cosío BG. Pérez de Llano L, et al. Respir Med. 2019 May;151:49-54. doi: 10.1016/j.rmed.2019.03.006. Epub 2019 Apr 1. Respir Med. 2019. PMID: 31047117 Free article. No abstract available.
Understanding Severe Asthma Through Small and Big Data in Spanish Hospitals: The PAGE Study.
Melero Moreno C, Almonacid Sánchez C, Bañas Conejero D, Quirce S, Álvarez Gutiérrez FJ, Cardona V, Sánchez-Herrero MG, Soriano JB; PAGE Study Group. Melero Moreno C, et al. J Investig Allergol Clin Immunol. 2023 Oct 16;33(5):373-382. doi: 10.18176/jiaci.0848. Epub 2023 Aug 24. J Investig Allergol Clin Immunol. 2023. PMID: 36000822 Free article.
Therapeutic Goals and Treatable Traits: Long-Term Trends in a Severe Asthma Population.
Almonacid-Sánchez C, Cosío BG, Trisán-Alonso A, Callejas-González FJ, Cisneros C, Martínez-Moragón E, Plaza Moral V, Vera E, Soto-Campos JG, Martínez-Rivera C, Alcazar-Navarrete B, Urrutia Landa I, García-Rivero JL, Padilla Galo A, Álvarez-Gutierrez F, Ramos-González J, Carretero-Gracia JÁ, Lluch I, Puente L, Andujar-Espinosa R, Pérez-de-Llano L. Almonacid-Sánchez C, et al. Arch Bronconeumol. 2023 Dec;59(12):842-845. doi: 10.1016/j.arbres.2023.08.017. Epub 2023 Oct 5. Arch Bronconeumol. 2023. PMID: 37865605 English, Spanish. No abstract available.
PAGE Study: Summary of a Study Protocol to Estimate the Prevalence of Severe Asthma in Spain Using Big Data Methods.
Almonacid Sánchez C, Melero Moreno C, Quirce Gancedo S, Sánchez-Herrero MG, Álvarez Gutiérrez FJ, Bañas Conejero D, Cardona V, Soriano JB. Almonacid Sánchez C, et al. J Investig Allergol Clin Immunol. 2021 Jul 26;31(4):308-315. doi: 10.18176/jiaci.0483. Epub 2020 Jan 23. J Investig Allergol Clin Immunol. 2021. PMID: 31983679 Free article.
Efficacy and Safety of Reslizumab in Patients with Severe Asthma with Inadequate Response to Omalizumab: A Multicenter, Open-Label Pilot Study.
Pérez de Llano LA, Cosío BG, Domingo C, Urrutia I, Bobolea I, Valero A, Entrenas Costa LM, Quirce S, Barranco P, Marina Malanda N, Andrés LP, Alvarez-Gutiérrez FJ. Pérez de Llano LA, et al. J Allergy Clin Immunol Pract. 2019 Sep-Oct;7(7):2277-2283.e2. doi: 10.1016/j.jaip.2019.01.017. Epub 2019 Jan 21. J Allergy Clin Immunol Pract. 2019. PMID: 30677539 Free article. Clinical Trial.
55 results